A multicenter, randomized, controlled trial of S-1/Cisplatin vs. Docetaxel/Cisplatin for treatment of untreated advanced lung cancer
Phase of Trial: Phase III
Latest Information Update: 20 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 16 Oct 2015 New source identified and integrated (JapicCTI111479).
- 16 Oct 2015 New trial record
- 06 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.